SCHEDULE 13D/A Filed 2026-08-14 Event 2026-08-12 SEC 0001072613-26-000686 →

SR ONE CAPITAL MANAGEMENT, LLC → Veradermics, Inc. MANE

Stake: — Shares: 2,080,119 Class: Common Stock, $0.00001 par value per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

12 transactions

0 buys · 10 sales · 2 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

8 filings by this filer

7 other filings in the data moat

Short Interest · settle 2026-09-30

DTC 4.68

4,244,476 shares short · +3.4% vs prior

Institutional Consensus · 2026-06-30

Held by elite portfolio managers

1 holder · $191.97M

Viking Global

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-08-17	Durso Timothy August	officer	Option exercise	3,452	$12.19	$42K
2026-08-17	Durso Timothy August	officer	Sale	7,918	$106.71	$845K
2026-08-17	Durso Timothy August	officer	Sale	16,306	$107.52	$1.75M
2026-08-17	Durso Timothy August	officer	Sale	16,767	$108.38	$1.82M
2026-08-17	Durso Timothy August	officer	Sale	2,348	$109.34	$257K
2026-08-17	Durso Timothy August	officer	Sale	161	$111.28	$18K
2026-08-17	Waldman Reid Alexander	director, officer	Option exercise	3,452	$12.19	$42K
2026-08-17	Waldman Reid Alexander	director, officer	Sale	11,527	$106.72	$1.23M
2026-08-17	Waldman Reid Alexander	director, officer	Sale	25,234	$107.53	$2.71M
2026-08-17	Waldman Reid Alexander	director, officer	Sale	27,490	$108.45	$2.98M
2026-08-17	Waldman Reid Alexander	director, officer	Sale	3,000	$109.38	$328K
2026-08-17	Waldman Reid Alexander	director, officer	Sale	249	$111.28	$28K

Other 13D/G Filings on Veradermics, Inc.

Filed	Form	Filer	Stake	Shares
2026-08-21	SCHEDULE 13D/A	MONTANOVA CAPITAL, LLC	8.80%	3,718,970	view →

Other Filings by SR ONE CAPITAL MANAGEMENT, LLC

Filed	Form	Issuer	Stake	Shares
2026-10-05	SCHEDULE 13D	ADARx Pharmaceuticals, Inc.	9.30%	9,936,661	view →
2026-08-17	SCHEDULE 13D/A	Zenas BioPharma, Inc.	—	5,037,854	view →
2026-05-18	SCHEDULE 13D	Odyssey Therapeutics, Inc. ODTX	8.00%	3,794,883	view →
2025-10-01	SCHEDULE	KALA BIO, Inc. KALA	5.50%	411,000	view →
2023-12-18	SC	Arcellx, Inc. ACLX	—	—	view →
2023-06-02	SC	Arcellx, Inc. ACLX	—	—	view →
2022-06-27	SC	Arcellx, Inc. ACLX	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →